Cagrilintide
CAS
1415456-99-3
MF
C194H312N54O59S2
MW
4409 g/mol
Purity
98%
Description

Cagrilintide is an amylin-analog, now being developed in combination with the GLP-1 agonist semaglutide to achieve sustained weight loss in persons with overweight and obesity